In addition, the breast cancer cell death was substantially higher although the expression of FN3K enhanced with certain kinase inhibitors used for breast cancer treatment and the Nrf2 signalling was modulated consequently NQO1 and HO-1 antioxidant protein expression patterns also declined. This evidence concerns the gene FN3K and breast cancer.